| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716e9a2606ffd4ba1a2a3917e4a402fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_430c89d97f6839f5364904e710af9704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f664356294234e6c9aed711394a36e40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 |
| filingDate |
2013-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b1731f44759e724ccc4afdcb7125502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4fa6c63745741a21a11540833a188e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18278a080873cd791b86082d1c7f110c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_741a1e33dcdb67134729d4c4975d0655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91992360b59e5c5faebf5d09cf646fa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d11152409dafd5858961ac852d328b04 |
| publicationDate |
2014-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201440791-A |
| titleOfInvention |
Polypeptide with radioactive gallium binding site and its radioactive gallium complex |
| abstract |
The polypeptide of the present invention or a salt thereof, which is a peptide derivative of exendin-4 or a salt thereof, wherein the polypeptide is formed from an amino acid sequence represented by "Y-QMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 (I)"; "Y-" means N-terminal α-amine group, and "B-DLSK(II)", "H2N-DLSX(III)", "B-HGEGTFTSDLSK(IV)" or "H2N-HGEGTFTSDLSX(V) The C-terminal carboxyl group of the amino acid sequence shown in any one of them forms a peptide bond; in the formulas (II) and (IV), the "B-" system represents a modified N using a modified group having a radioactive gallium binding site. In the formula (III) and (V), the "X" group represents an amino acid residue in which a side chain amine group is modified with a modifying group having a radioactive gallium bonding site; the above "B-" The N-terminal α-amino group and the side chain amine group of the above-mentioned "X"-depleted amino acid residue are modified by a modifying group having a radioactive gallium binding site represented by a predetermined general formula. |
| priorityDate |
2013-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |